The largest database of trusted experimental protocols

3 protocols using 4336 apc 050

1

AMPK Alpha 1 Subunit Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
ShPARG HeLa cells were plated in p100 plates with a density of 1 × 106 cells per plate and transfected with JetPEI reagent (Polyplus Transfection, Illkirch, France) with the plasmid pcDNA3-FLAG-AMPkα containing the wildtype and mutant forms of AMPk alpha 1 subunit, according to the manufacturer's guide. Twenty-four hours later, cells were starved at different times with HANK Buffer. After starvation, cells were washed 2 times with PBS1x Pefabloc 0.5 mM, resuspended in 500 μl of Lysis Buffer EBC (50 mMTris-HCl pH8, 120 mMNaCl, 0.5% NP-40, 1 mM PMSF, 1 mM Na3VO4, 10 mMNaF, Protease Inhibitor Complete Mini Roche), on ice 20 min. Centrifuge 13.000 rpm 20 min 4 °C and obtained the INPUT, the rest of supernatant was incubated with 35 μl of Protein Sepharose A (PAS) 1 hour 4 °C rocking. IP of endogenous PAR polymer performed using PAR (1:50) polyclonal antibody (4336-APC-050, TREVIGEN, My). IP was incubated at 4 °C o/n rocking and centrifuged 13.000 rpm 5 min 4 ºC. Pellets were washed 4 times with 500 μl of EBC 250-120 mMNaCl. Finally the pellet was resuspended in Loading Buffer 2x and maintained at -20 ºC.
+ Open protocol
+ Expand
2

Coimmunoprecipitation of Nuclear Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For coimmunoprecipitation, nuclear extracts were prepared using the Universal Magnetic Co-IP kit (Active Motif) in the presence of protease inhibitors (aprotinin, 10 μg/ml, Sigma; Pefabloc, 1 mM, Roche Applied Science), phosphatase inhibitor (sodium fluoride, 250 μM), and PARG inhibitor (DEA, 10 μM, Trevigen). Nuclear extracts (0.5 mg) were immunoprecipitated with NuMA antibodies or nonspecific IgG (1.5 μg) overnight at 4°C, and analyzed by immunoblotting. Similar results were obtained with two different NuMA antibodies (Calbiochem, ab-2 and Bethyl Laboratories, A301-509A). Antibodies used for immunoblot were 53BP1 (Abcam, Ab36823, 1 μg/ml), γH2AX (Ser139; Millipore, clone JBW301, 1 μg/ml), Histone H2B (Abcam, Ab1790, 0.1 μg/ml), lamin B (Abcam, Ab16048, 60 ng/ml), NuMA (B1C11, 1:2, a gift from Dr Jeffrey Nickerson, UMass, Worcester, USA), P-NuMA (S395; Cell Signaling, 3429, 1:1000), and PAR (Trevigen, 4336-APC-050, 1:1000).
+ Open protocol
+ Expand
3

Cervical Cancer Cell Line Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human cervical cancer cell lines SiHa and ME180 were obtained from ATCC and maintained in DMEM (Gibco) supplemented with 10% fetal bovine serum (Gibco) and 5% humidified CO2. PARP inhibitor Olaparib (AZD2281) was purchased from Selleckchem, Houston, USA. Cisplatin was purchased from Bio Vision, CA, USA. Anti-PARP antibody [clone 46D11, #9532 (WB 1:1000 and IF 1:800)], anti-vimentin [clone D21H3, #5741 (WB 1:1000)] and cell lysis buffer were obtained from Cell Signaling Technology, MA, USA. Anti-PAR antibody [#4336-APC-050 (WB 1:1200 and IF 1:400)] was purchased from Trevigen, MD, USA. Anti-γH2A.X (p-Ser139) antibody [clone EP854(2)Y, #ab81299 (IF 1:2000)] was purchased from Abcam, Alexa flour 488 anti-γH2A.X (phospho-S139) [clone 2F3, #613405 (IF 1:400 and FACS 1:200)] antibody was purchased from Bio Legend, San Diego, California and anti-GAPDH antibody [clone 2D4A7, #NB300–328 (WB 1:3000)] was obtained from Imgenex. XRCC4 (IF 1:200) and RPA (IF 1:400) antibodies were gifted by Dr. A.S. Balajee, Columbia University, New York, USA. XRCC1 (IF 1:500), 53BP (IF 1:500), RAD51 (IF 1:100) and Ku80 (IF 1:400) antibodies were kind gift from Dr. Sathees C. Raghavan, Indian Institute of Science, Bangalore.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!